Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;36(2):249-262.
doi: 10.1007/s10555-017-9673-1.

Platelets and cancer angiogenesis nexus

Affiliations
Review

Platelets and cancer angiogenesis nexus

Marek Z Wojtukiewicz et al. Cancer Metastasis Rev. 2017 Jun.

Abstract

There has been remarkable insight into the importance of platelets in a wide range of pathophysiologic events, including inflammation and cancer progression. Thrombocytosis in cancer patients is a common finding. Tumor cells induce platelet activation and subsequent aggregation through direct and indirect mechanisms. Platelets are recognized to contribute to metastatic dissemination. There is plenty of evidence that components of the hemostatic system contribute to the process of angiogenesis. Furthermore, there are accumulated data on the substantial influence of blood platelets in the process of blood vessel formation during malignancy. Platelets appear to be the main physiologic transporters of proangiogenic and antiangiogenic factors. Moreover, they influence the process of angiogenesis through platelet-derived microparticles, microRNA, lipids, and variety of surface receptors. Platelets contribute to early and late stages of angiogenesis. Available data support the overall stimulatory effect of platelets on tumor angiogenesis. It raises the possibility that interfering with platelet function may be an effective antineoplastic treatment strategy.

Keywords: Angiogenesis; Cancer; Growth factors; MicroRNA; Microparticles; Platelets; miRNAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Multidirectional influence of platelets on angiogenesis in malignancy. TCIPA tumor cell-induced platelet aggregation, TF tissue factor, PMPs platelet microparticles, miRNA microRNA

References

    1. Bizzozero J. Űber einen neunen formbestandteil des blutes und dessen rolle bei der thrombose und blutgerinnung. Virchows Archiv für Pathologische Anatomie und Physiologie und für Klinische Medizin. 1882;90:262–332.
    1. Geatano G. Historical overview of the role of platelets in hemostasis and thrombosis. Heamatologica. 2001;86:349–356. - PubMed
    1. Billroth T. Lectures on surgical pathology and therapeutics: a new handbook for students and practitioners. London: The New Sydenham Society; 1878. p. 355.
    1. Mac Kay W. The blood platelet: its clinical significance. Quartely Journal of Medicine. 1930;24:285–293.
    1. Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Memoli VA. Pathways of coagulation/fibrinolysis activation in malignancy. Seminars in Thrombosis and Hemostasis. 1992;18:104–116. doi: 10.1055/s-2007-1002415. - DOI - PubMed

LinkOut - more resources